Tag Archives: COLCOT

Colchicina post infarto: buenos resultados y costo-efectivo

Post-MI Colchicine: Cost-Effective with Good Results

Post-MI Colchicine: Cost-Effective with Good Results

Low colchicine doses reduce the risk of post-AMI ischemic events according to the COLCOT trial, originally presented at AHA 2019 scientific sessions, and simultaneously published in NEJM. The new information delivered at the virtual ACC 2020 addresses its cost-effectiveness. Colchicine is an anti-inflammatory drug indicated in the treatment of gout and pericarditis, but its price

Top